State Action
CCAGW Urges Virginia Senators to Oppose Senate Bill 274
SB 274 which would impose price controls on prescription drugs.
CCAGW Urges Indiana Legislators to Oppose Senate Bill 3
SB3 would ban PBMs from utilizing formularies to reduce patient costs.
CCAGW Urges West Virginia Legislators to Oppose Senate Bill 325
SB 325 would make changes to the federal 340B drug discount program.
CCAGW Urges West Virginia Legislators to Oppose SB 325
SB 325 would change how the federal 340B program operates in the Mountain State.
CCAGW Urges Kentucky Legislators to Oppose Senate Bill 27
SB 27 would change how the federal 340B program operates in the Commonwealth of Kentucky.
CCAGW Urges Missouri Legislators to Support House Bill 2057
HB 2057 would clarify that municipalities may not impose franchise fees on online streaming services.
CCAGW Urges Nevada Senate to Oppose SB 509
SB 509 would grant $380 million in public subsidies and tax breaks for the construction of a stadium for the Oakland Athletics in Las Vegas.
CCAGW Urges Maine Joint Judiciary Committee to Oppose LD 1973
LD 1973 will fail to achieve its objective of protecting consumer privacy.
CCAGW Urges North Carolina Senate Health Care Committee to Oppose HB 246
HB 246 would impose onerous regulations on pharmacy benefit managers.
CCAGW Urges North Carolina Senate Commerce and Insurance Committee to Oppose HB 246
HB 246 would impose onerous regulations on pharmacy benefit managers.
CCAGW Urges Minnesota House of Representatives to Remove Prescription Drug Affordability Board Provisions From SF 2744
Price controls distort markets, hurt innovation, and exacerbate the problems they are created to fix.
CCAGW Urges Florida Senate Rules Committee to Oppose SB 262
SB 262 would harm consumers and small businesses.
